Newsletter: Clinical value of cystatin C #KidneyMonth
29. Mar 2021 |
6 min read
This year's #KidneyMonth focuses on managing Chronic Kidney Disease (CKD). At Gentian, we believe that the integration of cystatin C into clinical workflows can have a profound impact on both the quality and the efficiency of kidney care delivery, especially in relation to CKD.
In recognition of #KidneyMonth, we have launched The Cystatin C Digest webinar series, in which we will summarise some of the latest research pertaining to the clinical use of cystatin C. Our aim is to regularly promote The cystatin C digest series to share new research and knowledge about kidney health and cystatin C. If you are aware of any research projects or studies that should be included as part of this series, please let us know by reaching out to us at firstname.lastname@example.org.
The American Society of Nephrology and the National Kidney Foundation came with a statement on the 09.03.2021iterating that “race modifiers should not be included in equations that estimate kidney function” and that “current race-based equations should be replaced in every laboratory in the US by a suitable approach that is accurate, inclusive, and standardised.” We also hope you enjoy our webinar on the clinical value of incorporating cystatin C testing into medication dosing and monitoring protocols, and our article on the history of eGFR.
Webinar: The Cystatin C Digest - Feb 2021
Our first webinar in our newly launched Cystatin C Digest webinar series. In this series we will summarise some of the exceptional and new research being conducted on the clinical use of Cystatin C.
Shortcomings of the current standard of kidney care
Cystatin C testing can help ensure an unbiased assessment of renal function, which is central to diagnosis and management of kidney disease. The use of race in clinical algorithms used to detect and manage kidney disease have contributed to major kidney-health disparities. A joint statement made by the American Society of Nephrology and the National Kidney Foundation on March 9th of this year states:
“Race modifiers should not be included in equations that estimate kidney function.”
“Current race-based equations should be replaced by a suitable approach that is accurate, inclusive, and standardized in every laboratory in the US.”
The hope is that clinical implementation of equations that provide an unbiased assessment of kidney function would allow health professionals to ensure equitable outcomes in all patients with kidney disease. Read more.
A brief history on the estimation of Glomerular Filtration Rate
Glomerular filtration rate (GFR) is a measure of how much blood is filtered by the kidneys each minute, and it is the best overall indicator for how well an individual’s kidneys are functioning at a given moment. If you are interested in the history of GFR you can read more here.
Webinar: Clinical value of cystatin C in drug dosing
In our fourth webinar in Gentian's cystatin C webinar series, we focus on two real-world scenarios to illustrate the clinical value of incorporating cystatin C testing into medication dosing and monitoring protocols.